|
BMS-303141
- 英文名称：BMS-303141
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B10306
- cas：943962-47-8
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-12-08
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10306 |
| 用途 | 科研检测 |
| 英文名称 | BMS-303141 |
| 包装规格 | 1MG |
| CAS编号 | 943962-47-8 |
| 别名 | BMS-303141 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by TLC;NMR (Conforms)
分子式:C19H15Cl2NO4S
分子量:424.30
溶剂:DMSO (25 mg/ml) Ethanol (20 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):ATP citrate lyase (ACL) inhibitor
Function / Pharmacology:Potent and selective ATP citrate lyase (ACL) inhibitor, IC50=0.13 ?M. Inhibits lipid biosynthesis, IC50=8 ?M in HepG2 cells.1,2 Reduces weight gain, lowers plasma cholesterol, triglycerides and glucose in high-fat-fed mice.2 A novel tool compound for exploring the potential of ACL inhibition as a target for metabolic disorders such as obesity and dyslipidemia.2 Impairs proliferation or induces death in androgen-depleted castration resistant prostate cancer cells.3 Reduces cell cycle progression in iBN cells.4
分子式:C19H15Cl2NO4S
分子量:424.30
溶剂:DMSO (25 mg/ml) Ethanol (20 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):ATP citrate lyase (ACL) inhibitor
Function / Pharmacology:Potent and selective ATP citrate lyase (ACL) inhibitor, IC50=0.13 ?M. Inhibits lipid biosynthesis, IC50=8 ?M in HepG2 cells.1,2 Reduces weight gain, lowers plasma cholesterol, triglycerides and glucose in high-fat-fed mice.2 A novel tool compound for exploring the potential of ACL inhibition as a target for metabolic disorders such as obesity and dyslipidemia.2 Impairs proliferation or induces death in androgen-depleted castration resistant prostate cancer cells.3 Reduces cell cycle progression in iBN cells.4
